• Behavioral Health
  • Consumer Stories
  • People-first Pharmacy Care

Genoa Healthcare® Director of Operations featured in Chain Drug Review’s “Excellence in Pharmacy Practice” profile series

Oct 23rd, 2024

Alicia Garcia Afa, PharmD, RPh, a Genoa Healthcare director of pharmacy operations and previous pharmacist who recently helped a consumer navigate a mental health crisis, was featured in Chain Drug Review’s pharmacy profile series highlighting the important role of pharmacists within their communities.

In the article, Alicia shared how she grew up watching her father, who recently retired from pharmacy practice in December 2023, make a positive impact in the lives of others, which inspired her to follow in his footsteps. She also detailed how she makes it a point to build a relationship with every person she serves.

“We’re here to support, to help, to care for our consumers,” said Alicia. “We’re not here to judge or to lecture. I make it clear to my consumers that I will meet them exactly where they’re at, however best I can.”

Read the full article here.

Recent Posts


  • 340B
340B made easy: 5 traits to look for in a contract pharmacy partner

The 340B Drug Pricing Program helps participating organizations – or covered entities – use savings on prescription drug costs to offer more comprehensive services and care for more eligible patients....

  • Behavioral Health
  • Clinical Insights
  • Treatment
Quick guide to recently approved behavioral health medications

Keeping up with new and emerging treatment options for your consumers can be difficult. Genoa Healthcare’s Tim Krause, PharmD, compiled a quick guide to share the latest on recently approved...

  • Clinical Insights
  • Treatment
Long-acting injectables in practice: What providers need to know

Genoa Healthcare recently hosted a webinar where Senior Product Manager Blake Shoemaker, PharmD, discussed long-acting injectables (LAIs) in practice. Watch the recording below for an overview on benefits, challenges and...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....